Infectious Disease Therapeutics Market Size, Share, Trends, Segmental Analysis By Drug Class (Antiviral Therapeutics [HIV Antiretrovirals, Hepatitis B and C Antivirals, Respiratory Antivirals, Other Antiviral Drugs], Antibiotic Therapeutics [Broad-Spectrum Antibiotics, Narrow-Spectrum/Targeted Antibiotics, Novel Antibiotic Classes], Antifungal Therapeutics [Azoles, Echinocandins, Polyenes, Novel Antifungal Agents], Antiparasitic Therapeutics [Antimalarials, Antiprotozoals, Antihelminthics], Other Drug Classes), By Indication (HIV/AIDS, Hepatitis B and C, Tuberculosis, Respiratory Infections, Sexually Transmitted Infections, Fungal Infections, Parasitic Infections, Other Indications), By Mode of Administration (Oral, Injectable/Intravenous, Topical, Other Modes), By Distribution Channel (Hospital Pharmacies, Retail and Community Pharmacies, Government and Public Health Programs, Online Pharmacies, Other Channels), By End User (Hospitals and Tertiary Care Centers, Specialty Infectious Di

Infectious Disease Therapeutics Market Size to Hit USD 161.72 Billion by 2033